Jonathan Goldman - Mar 27, 2024 Form 3 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Donald R. Reynolds by power of attorney
Stock symbol
AVTX
Transactions as of
Mar 27, 2024
Transactions value $
$0
Form type
3
Date filed
4/3/2024, 04:04 PM
Next filing
Aug 14, 2024

No securities are beneficially owned.